Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amylyx Pharmaceuticals (AMLX) Exchange Rate Effect: 2021-2025

Historic Exchange Rate Effect for Amylyx Pharmaceuticals (AMLX) over the last 4 years, with Sep 2025 value amounting to $151,000.

  • Amylyx Pharmaceuticals' Exchange Rate Effect fell 36.02% to $151,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $431,000, marking a year-over-year increase of 33.02%. This contributed to the annual value of -$438,000 for FY2024, which is 373.75% down from last year.
  • Per Amylyx Pharmaceuticals' latest filing, its Exchange Rate Effect stood at $151,000 for Q3 2025, which was down 75.16% from $608,000 recorded in Q2 2025.
  • In the past 5 years, Amylyx Pharmaceuticals' Exchange Rate Effect registered a high of $608,000 during Q2 2025, and its lowest value of -$525,000 during Q4 2024.
  • In the last 3 years, Amylyx Pharmaceuticals' Exchange Rate Effect had a median value of $75,000 in 2023 and averaged $61,636.
  • Data for Amylyx Pharmaceuticals' Exchange Rate Effect shows a peak YoY increase of 5,533.33% (in 2022) and a maximum YoY decrease of 18,550.00% (in 2022) over the last 5 years.
  • Quarterly analysis of 5 years shows Amylyx Pharmaceuticals' Exchange Rate Effect stood at $9,000 in 2021, then skyrocketed by 5,533.33% to $507,000 in 2022, then plummeted by 53.25% to $237,000 in 2023, then plummeted by 321.52% to -$525,000 in 2024, then plummeted by 36.02% to $151,000 in 2025.
  • Its last three reported values are $151,000 in Q3 2025, $608,000 for Q2 2025, and $197,000 during Q1 2025.